Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Cerebrospinal Fluid Management Devices Companies

Cerebrospinal fluid (CSF) management devices are used in neurosurgical procedures to manage the flow and pressure of cerebrospinal fluid in and around the brain and spinal cord. These devices are crucial in the treatment of conditions such as hydrocephalus and other neurosurgical interventions.

Latest Cerebrospinal Fluid Management Devices Companies Update

July 2023: Anuncia Medical Inc., an organization dedicated to the development of innovations in neurocritical care and implantable and external cerebrospinal fluid (CSF) management systems, is delighted to declare the ReFlow™ Mini Flusher device officially available for purchase in the United States. Neurosurgeons in the United States and, in the near future, around the globe will have an additional avenue to mitigate the effects of hydrocephalus by facilitating access to potentially life-saving treatments for the 30 million patients affected by this neurological disorder. Hydrocephalus, a chronic neurological disorder characterized by the accumulation of extracellular saline (CSF) in the brain, frequently results in life-threatening complications, frequent hospitalizations, and severe symptoms.

January 2023: Biogen Inc. and Alcyone Therapeutics entered into a license and collaboration agreement in January 2023 for the development of Alcyone's ThecaFlex DRx™ System, an implantable medical device designed to deliver antisense oligonucleotide therapies into the intrathecal space via subcutaneous delivery. Biogen endeavors to utilize the ThecaFlex DRx™ System in this agreement to enhance the treatment experience for patients and expand accessibility to a wider demographic afflicted with neurological disorders, including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). Potentially the first implantable device to facilitate routine subcutaneous administration of ASO therapies to the cerebrospinal fluid, the ThecaFlex DRx™ System possesses this capability. In Europe, the ThecaFlex DRx™ System has been granted the CE Mark. The ThecaFlex DRx™ System was developed by Alcyone as an alternative therapeutic delivery method for patients suffering from chronic neurological conditions that necessitate recurrent lumbar puncture for treatment purposes.

List of Cerebrospinal Fluid Management Devices Key companies in the market

Medtronic Plc (Ireland)

Natus Medical Incorporated (US)

Braun Melsungen AG (Germany)

Sophia (France)

IRRAS AB (Sweden)

Möller Medical GmbH (Germany)

Argi Grup (Turkey)

Longeviti (US)

Integra Lifesciences Corporation (US)

Cerebrospinal Fluid Management Devices Market Highlights:

Cerebrospinal Fluid Management Devices Market Size

Cerebrospinal Fluid Management Devices Market Trends

Cerebrospinal Fluid Management Devices Market Analysis

Cerebrospinal Fluid Management Devices Market Share

Cerebrospinal Fluid Management Devices Market Highlights:

Cerebrospinal Fluid Management Devices Market Trends

Cerebrospinal Fluid Management Devices Market Analysis

Cerebrospinal Fluid Management Devices Market Share

Cerebrospinal Fluid Management Devices Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.